A baseline tool for predicting response to peginterferon alfa‐2a in HBeAg‐positive patients with chronic hepatitis B. - Chan, H. L. Y.; Messinger, D.; Papatheodoridis, G. V.; Cornberg, M.; Xie, Q.; Piratvisuth, T.; Ren, H.; Kennedy, P. T.; Thompson, A.; Caputo, A.; Bakalos, G.; Pavlovic, V.; et al. (Alimentary Pharmacology & Therapeutics, 2018)